XML 65 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value of Financial Instruments (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jan. 01, 2023
Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Gains or losses included in earnings attributable to the change in realized/unrealized gains or losses related to the assets $ 0 $ 0      
Fair value, assets, level 1 to level 2 transfers, amount 0 0      
Fair value, assets, level 2 to level 1 transfer, amount 0 0      
Credit loss expense/(credit) - loans 414,000 (419,000)      
Nonaccrual loans 3,258,000   $ 3,495,000    
Allowance for loan losses (16,871,000) $ (15,292,000) (14,636,000) $ (16,702,000) $ (15,955,000)
Loans 1,289,080,000   1,279,494,000    
Impaired Loans with Specific Allowance: Recorded Investment     345,000    
Impaired Loans with Specific Allowance: Related Allowance     26,000    
Impaired Loans with No Specific Allowance: Recorded Investment     6,153,000    
Financing receivables minimum benchmark for evaluation for specific reserves 100,000        
Financing receivable individually evaluated with no allowance carrying value 2,300,000        
Partial Charge Off [Member]          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Nonaccrual loans $ 200,000   100,000    
Troubled Debt Restructuring [Member]          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Credit loss expense/(credit) - loans     1,300,000    
Allowance for loan losses     (400,000)    
Impaired Loans with Specific Allowance: Recorded Investment     1,000,000.0    
Impaired Loans with Specific Allowance: Related Allowance     $ 64,700